Affluent Medical | Finanzwire

BRIEF

published on 07/08/2026 at 11:50, 13 days 19 hours ago

Carvolix Liquidity Contract Review for the First Half of 2026

Liquidity Contract Semi-annual Transactions Rothschild & Co Carvolix Securities Management
BRIEF

published on 07/06/2026 at 07:05, 16 days ago

Promising data for Carvolix's TAVIPILOT at the New York Valves 2026

Artificial Intelligence Carvolix Medical Robotics TAVIPILOT New York Valves 2026
PRESS RELEASE

published on 07/06/2026 at 07:00, 16 days ago

Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026
Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026, showing excellent results for aortic valve positioning. The AI-driven software and robot aim to revolutionize TAVI procedures

AI-driven Clinical Data Carvolix TAVIPILOT New York Valves 2026
BRIEF

published on 06/24/2026 at 07:35, 28 days ago

Carvolix Secures €10 Million in Funding for its Development Program

Funding Medicine Carvolix TAVIPILOT Venture Debt
BRIEF

published on 06/24/2026 at 07:35, 28 days ago

Carvolix Gains EUR 10m Tranche, Reaching EUR 20m in Financing

Medical Technology Shareholder Confidence AI-driven Robotics Venture Debt Carvolix Financing
PRESS RELEASE

published on 06/24/2026 at 07:30, 28 days ago

Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
Carvolix secures new EUR 10m tranche, bringing total financing to EUR 20m as part of its EUR 30m programme. Proceeds for commercialization and regulatory advancements

Financing Regulatory Developments Carvolix TAVIPILOT EUR 10m
BRIEF

published on 06/15/2026 at 17:50, 1 month 6 days ago

Carvolix: Positive results at 3 years for the Kalios™ mitral ring

Mitral Regurgitation Clinical Results Carvolix Kalios Mitral Ring
BRIEF

published on 06/15/2026 at 17:50, 1 month 6 days ago

Carvolix Reports Positive 3-Year Results for Kalios™ Mitral Ring

Mitral Regurgitation Clinical Results Kalios™ Carvolix Adjustable Mitral Ring
PRESS RELEASE

published on 06/15/2026 at 17:45, 1 month 6 days ago

Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation.
Carvolix announces positive 3-year clinical results for Kalios™, the adjustable mitral ring, with 100% of patients meeting primary endpoint for mitral regurgitation. Company plans FDA submission in 2027

FDA Submission Clinical Results Carvolix Kalios Mitral Ring
BRIEF

published on 06/15/2026 at 17:45, 1 month 6 days ago

Carvolix Announces the Number of Voting Rights as of May 31, 2026

Share Capital Voting Rights Financial Transparency Medical Afflict Carvolix

Published on 07/22/2026 at 03:10, 4 hours 39 minutes ago

High Tide Resources Corp. Announces Change of Auditor
Published on 07/22/2026 at 02:30, 5 hours 19 minutes ago

Avidian Gold Corp. Announces Change of Auditor
Published on 07/21/2026 at 23:00, 8 hours 49 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Published on 07/21/2026 at 22:30, 9 hours 19 minutes ago

Fermi Announces First Siemens Turbines Arrive at Port of Houston
Published on 07/21/2026 at 22:30, 9 hours 19 minutes ago

Matador Technologies Announces Management Transition

View all ACCESSWIRE

Published on 07/22/2026 at 07:30, 19 minutes ago

MANAGEMENT STATEMENT FOR THE FIRST QUARTER ENDED 30 JUNE 2026
Published on 07/22/2026 at 07:30, 19 minutes ago

Media Release: DynamiQ-X universal: a next generation micro-gas chromatograph built for global deployment
Published on 07/22/2026 at 07:26, 23 minutes ago

BaFin Review Concerns Recognition of Pentixapharm Spin-off in 2024 Consolidated Financial Statements. Potential Income from Discontinued Operations Without Impact on Operating Key Figures.
Published on 07/22/2026 at 07:22, 27 minutes ago

Intershop publishes figures for the first half of 2026
Published on 07/22/2026 at 07:13, 36 minutes ago

EQS-Adhoc: FRIEDRICH VORWERK increases EBITDA by 70 % to €93 million in the first half of the year and raises its forecast to €180-200 million EBITDA, whilst revenue expectations remain unchanged

View all EQS

Published on 07/22/2026 at 07:00, 49 minutes ago

TINC invests in 2 battery energy storage systems developed by BSTOR, and strengthens its role in the Belgian energy transition
Published on 07/22/2026 at 06:59, 50 minutes ago

2026 Half-year results - Press Release
Published on 07/21/2026 at 18:41, 13 hours 8 minutes ago

ICADE - 2026 HY Financial Report
Published on 07/21/2026 at 18:13, 13 hours 36 minutes ago

ICADE – PR – 2026 HALF YEAR RESULTS
Published on 07/20/2026 at 18:20, 1 day 13 hours ago

Covivio - 2026 Half-year results: Earnings growth driven by active asset management

View all LES ECHOS COMFI WIRE

News